Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Drug tapering noninferior to treatment continuation for rheumatoid arthritis with low disease activity

For patients with rheumatoid arthritis (RA) with sustained low disease activity (LDA), structured tapering of biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) is noninferior to treatment continuation for maintaining disease control over 24 weeks, according to a study published online Oct. 6 in Arthritis & Rheumatology.

Drug tapering noninferior to treatment continuation for rheumatoid arthritis with low disease activity

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Tuesday 13 October →